BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Internationally Known Medical Device Regulatory Expert, Haroon Atchia Has Published the First Fundamental and Critical Examination of the Proposal Regulation


4/29/2013 11:21:32 AM

London, 24 April 2013 - Haroon Atchia - CEO of the London-based medical device regulatory consultancy Quality First International - has written the first available in-depth examination of the proposal of a new medical device regulation in the European Union, as submitted by DG SANCO of the European Commission, Brussels.

The document offers an encompassing, one-stop access to the subject and facilitates examination and exploration of the proposed new regulation by dissecting the large proposal into discrete elements.

In his report Mr Atchia examines the questions:

- Which areas of the new regulation could present problems in efficient control of medical devices throughout Europe?

- What are the responsibilities of the different parties involved in manufacture, marketing, distribution and sale?

- What are the responsibilities and powers of the authorities involved?

- What are the changes from the prevailing Medical Device Directive 93/42/EEC (as amended)?

- Which opportunities for solving current regulatory problems have been missed by the Commission?

- Can real improvement be accomplished at all?

Title: Decoding European Union Medical Device proposal Regulation (COM (2012) 542 final 0266 (COD) – New requirements, changes, responsibilities, implementing and missed opportunities

Specifications: 336 pages, PDF. Including tables and graphs.

Available for sale through: www.qualityfirstint.com, price: £399 + VAT as a special offer running 7 days, after that the price will increase to £499 + VAT

About Quality First International

Quality First International (QFI) is a London-based medical devices consulting company specialising in solving its clients’ regulatory, technical and compliance challenges to enable medical devices to enter the global marketplace. Quality First International provides regulatory advice, quality assurance and clinical trial services, with particular emphasis on the European, US, Japanese, Australian, Canadian, Mexican and Chinese marketplaces. All submissions made by Quality First International have fulfilled the compliance requirements first time round, consistently. Quality First International’s clients range from start-up companies to multinational organisations, primarily developing a broad range of cutting edge, minimally invasive and cardiovascular products and implants.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES